Intra-Cellular Therapies Inc (ITCI)
64.96
-0.60
(-0.92%)
USD |
NASDAQ |
May 10, 16:00
64.96
0.00 (0.00%)
After-Hours: 20:00
Intra-Cellular Therapies Market Cap: 6.858B for May 10, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 10, 2024 | 6.858B |
| May 09, 2024 | 6.921B |
| May 08, 2024 | 7.074B |
| May 07, 2024 | 7.518B |
| May 06, 2024 | 7.497B |
| May 03, 2024 | 7.264B |
| May 02, 2024 | 7.426B |
| May 01, 2024 | 7.678B |
| April 30, 2024 | 7.581B |
| April 29, 2024 | 7.633B |
| April 26, 2024 | 7.734B |
| April 25, 2024 | 7.615B |
| April 24, 2024 | 7.719B |
| April 23, 2024 | 7.721B |
| April 22, 2024 | 7.777B |
| April 19, 2024 | 7.054B |
| April 18, 2024 | 7.018B |
| April 17, 2024 | 7.476B |
| April 16, 2024 | 7.783B |
| April 15, 2024 | 6.313B |
| April 12, 2024 | 6.422B |
| April 11, 2024 | 6.626B |
| April 10, 2024 | 6.558B |
| April 09, 2024 | 6.689B |
| April 08, 2024 | 6.599B |
| Date | Value |
|---|---|
| April 05, 2024 | 6.671B |
| April 04, 2024 | 6.551B |
| April 03, 2024 | 6.562B |
| April 02, 2024 | 6.499B |
| April 01, 2024 | 6.655B |
| March 28, 2024 | 6.699B |
| March 27, 2024 | 6.749B |
| March 26, 2024 | 6.518B |
| March 25, 2024 | 6.580B |
| March 22, 2024 | 6.682B |
| March 21, 2024 | 6.620B |
| March 20, 2024 | 6.506B |
| March 19, 2024 | 6.336B |
| March 18, 2024 | 6.328B |
| March 15, 2024 | 6.271B |
| March 14, 2024 | 6.251B |
| March 13, 2024 | 6.313B |
| March 12, 2024 | 6.231B |
| March 11, 2024 | 6.334B |
| March 08, 2024 | 6.533B |
| March 07, 2024 | 6.459B |
| March 06, 2024 | 6.392B |
| March 05, 2024 | 6.449B |
| March 04, 2024 | 6.508B |
| March 01, 2024 | 6.921B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
401.10M
Minimum
Oct 01 2019
7.783B
Maximum
Apr 16 2024
3.564B
Average
3.455B
Median
Jul 01 2021
Market Cap Benchmarks
| Johnson & Johnson | 360.79B |
| Insmed Inc | 3.859B |
| Madrigal Pharmaceuticals Inc | 4.374B |
| Vertex Pharmaceuticals Inc | 109.10B |
| Fate Therapeutics Inc | 404.89M |
Market Cap Related Metrics
| PS Ratio | 12.21 |
| Price to Book Value | 11.44 |
| Price | 64.96 |
| Earnings Yield | -1.79% |